artenimol has been researched along with Leukemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Jing, Y; Li, M; Liu, D; Song, D; Tan, J; Wang, W; Yang, X; Zhao, L | 1 |
| Ai, Z; Dong, R; Jin, S; Wang, L; Wei, H; Zhang, X; Zhang, Z | 1 |
| Lai, HC; Park, J; Sasaki, T; Singh, M; Singh, NP | 1 |
| Chan, HW; Fang, Q; Gerhardt, T; Jones, R; Lai, H; Lu, R; Park, J; Singh, N | 1 |
| Arellano, ML; Boggon, TJ; Chen, J; Elf, S; Fan, J; Gaddh, M; Khoury, HJ; Khuri, FR; Lee, BH; Lin, R; Lonial, S; Pan, Y; Shan, C; Wu, S; Xia, S | 1 |
| Chen, H; Gerhard, GS; Zhang, S | 1 |
| Budhraja, A; Chen, D; Chen, J; Cheng, S; Gao, N; Huang, C; Liu, EH; Shi, X; Yang, Z; Zhang, Z | 1 |
| Ding, XP; Gao, JL; Li, QJ; Xia, QJ; Xia, ZL | 1 |
8 other study(ies) available for artenimol and Leukemia
| Article | Year |
|---|---|
Synthesis of a series of novel dihydroartemisinin derivatives containing a substituted chalcone with greater cytotoxic effects in leukemia cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Line, Tumor; Cell Proliferation; Chalcones; Chemistry, Pharmaceutical; Drug Design; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia; Mice; Models, Chemical | 2009 |
Dihydroartemisinin Triggers Ferroptosis in Multidrug-Resistant Leukemia Cells.
Topics: Antioxidants; Artemisinins; Doxorubicin; Drug Resistance, Multiple; Ferroptosis; Humans; Iron; Leukemia; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; TOR Serine-Threonine Kinases | 2022 |
Development of a dihydroartemisinin-resistant Molt-4 leukemia cell line.
Topics: Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Leukemia; Transferrin; Tumor Cells, Cultured | 2014 |
Effects of antioxidants and pro-oxidants on cytotoxicity of dihydroartemisinin to Molt-4 human leukemia cells.
Topics: Antioxidants; Apoptosis; Artemisinins; Ascorbic Acid; Cell Line, Tumor; Cholecalciferol; Chromans; Dexamethasone; Humans; Hydrogen Peroxide; Leukemia; Oxidation-Reduction; Reactive Oxygen Species | 2015 |
Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.
Topics: Animals; Antimalarials; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Cell Line, Tumor; Cell Survival; Drug Synergism; Emodin; Female; Humans; K562 Cells; Leukemia; Mice; Mice, Nude; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Xenograft Model Antitumor Assays | 2017 |
Heme synthesis increases artemisinin-induced radical formation and cytotoxicity that can be suppressed by superoxide scavengers.
Topics: Antimalarials; Artemisinins; Catalase; Cell Death; Cell Line, Tumor; Cytotoxins; Dicarbethoxydihydrocollidine; Fluoresceins; Free Radical Scavengers; Glutathione Peroxidase; Heme; Humans; Leukemia; Reactive Oxygen Species; Superoxide Dismutase; Superoxides | 2010 |
Interruption of the MEK/ERK signaling cascade promotes dihydroartemisinin-induced apoptosis in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Caspases; Cytochromes c; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Leukemia; MAP Kinase Kinase Kinases; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; U937 Cells; Xenograft Model Antitumor Assays | 2011 |
[Effect of dihydroartemisinin on the expression of BCR/ABL fusion gene in leukemia K562 cells].
Topics: Artemisinins; Fusion Proteins, bcr-abl; Gene Expression; Genes, abl; Humans; K562 Cells; Leukemia; Tumor Cells, Cultured | 2012 |